221 related articles for article (PubMed ID: 12356736)
1. Transcription factor Sp3 is silenced through SUMO modification by PIAS1.
Sapetschnig A; Rischitor G; Braun H; Doll A; Schergaut M; Melchior F; Suske G
EMBO J; 2002 Oct; 21(19):5206-15. PubMed ID: 12356736
[TBL] [Abstract][Full Text] [Related]
2. SUMO modification of STAT1 and its role in PIAS-mediated inhibition of gene activation.
Rogers RS; Horvath CM; Matunis MJ
J Biol Chem; 2003 Aug; 278(32):30091-7. PubMed ID: 12764129
[TBL] [Abstract][Full Text] [Related]
3. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism.
Spengler ML; Kennett SB; Moorefield KS; Simmons SO; Brattain MG; Horowitz JM
Cell Signal; 2005 Feb; 17(2):153-66. PubMed ID: 15494207
[TBL] [Abstract][Full Text] [Related]
4. Role for SUMO modification in facilitating transcriptional repression by BKLF.
Perdomo J; Verger A; Turner J; Crossley M
Mol Cell Biol; 2005 Feb; 25(4):1549-59. PubMed ID: 15684403
[TBL] [Abstract][Full Text] [Related]
5. Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription.
Ling Y; Sankpal UT; Robertson AK; McNally JG; Karpova T; Robertson KD
Nucleic Acids Res; 2004; 32(2):598-610. PubMed ID: 14752048
[TBL] [Abstract][Full Text] [Related]
6. SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization.
Ross S; Best JL; Zon LI; Gill G
Mol Cell; 2002 Oct; 10(4):831-42. PubMed ID: 12419227
[TBL] [Abstract][Full Text] [Related]
7. An inhibitor domain in Sp3 regulates its glutamine-rich activation domains.
Dennig J; Beato M; Suske G
EMBO J; 1996 Oct; 15(20):5659-67. PubMed ID: 8896459
[TBL] [Abstract][Full Text] [Related]
8. SUMO-1 modification activated GATA4-dependent cardiogenic gene activity.
Wang J; Feng XH; Schwartz RJ
J Biol Chem; 2004 Nov; 279(47):49091-8. PubMed ID: 15337742
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of Tbx5-mediated transactivation by SUMO conjugation and protein inhibitor of activated STAT 1 (PIAS1).
Beketaev I; Kim EY; Zhang Y; Yu W; Qian L; Wang J
Int J Biochem Cell Biol; 2014 May; 50():82-92. PubMed ID: 24582888
[TBL] [Abstract][Full Text] [Related]
10. Transcription factor Sp3 is regulated by acetylation.
Braun H; Koop R; Ertmer A; Nacht S; Suske G
Nucleic Acids Res; 2001 Dec; 29(24):4994-5000. PubMed ID: 11812829
[TBL] [Abstract][Full Text] [Related]
11. PIAS proteins promote SUMO-1 conjugation to STAT1.
Ungureanu D; Vanhatupa S; Kotaja N; Yang J; Aittomaki S; Jänne OA; Palvimo JJ; Silvennoinen O
Blood; 2003 Nov; 102(9):3311-3. PubMed ID: 12855578
[TBL] [Abstract][Full Text] [Related]
12. PIAS1 enhances SUMO-1 modification and the transactivation activity of the major immediate-early IE2 protein of human cytomegalovirus.
Lee JM; Kang HJ; Lee HR; Choi CY; Jang WJ; Ahn JH
FEBS Lett; 2003 Dec; 555(2):322-8. PubMed ID: 14644436
[TBL] [Abstract][Full Text] [Related]
13. PIAS1 is a GATA4 SUMO ligase that regulates GATA4-dependent intestinal promoters independent of SUMO ligase activity and GATA4 sumoylation.
Belaguli NS; Zhang M; Garcia AH; Berger DH
PLoS One; 2012; 7(4):e35717. PubMed ID: 22539995
[TBL] [Abstract][Full Text] [Related]
14. Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9.
Komatsu T; Mizusaki H; Mukai T; Ogawa H; Baba D; Shirakawa M; Hatakeyama S; Nakayama KI; Yamamoto H; Kikuchi A; Morohashi K
Mol Endocrinol; 2004 Oct; 18(10):2451-62. PubMed ID: 15192080
[TBL] [Abstract][Full Text] [Related]
15. Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification.
Tallec LP; Kirsh O; Lecomte MC; Viengchareun S; Zennaro MC; Dejean A; Lombès M
Mol Endocrinol; 2003 Dec; 17(12):2529-42. PubMed ID: 14500761
[TBL] [Abstract][Full Text] [Related]
16. NMR structure of the N-terminal domain of SUMO ligase PIAS1 and its interaction with tumor suppressor p53 and A/T-rich DNA oligomers.
Okubo S; Hara F; Tsuchida Y; Shimotakahara S; Suzuki S; Hatanaka H; Yokoyama S; Tanaka H; Yasuda H; Shindo H
J Biol Chem; 2004 Jul; 279(30):31455-61. PubMed ID: 15133049
[TBL] [Abstract][Full Text] [Related]
17. Complexity of translationally controlled transcription factor Sp3 isoform expression.
Sapetschnig A; Koch F; Rischitor G; Mennenga T; Suske G
J Biol Chem; 2004 Oct; 279(40):42095-105. PubMed ID: 15247228
[TBL] [Abstract][Full Text] [Related]
18. SUMO represses transcriptional activity of the Drosophila SoxNeuro and human Sox3 central nervous system-specific transcription factors.
Savare J; Bonneaud N; Girard F
Mol Biol Cell; 2005 Jun; 16(6):2660-9. PubMed ID: 15788563
[TBL] [Abstract][Full Text] [Related]
19. PIAS1 negatively regulates ubiquitination of Msx1 homeoprotein independent of its SUMO ligase activity.
Song YJ; Lee H
Mol Cells; 2011 Sep; 32(3):221-6. PubMed ID: 21717107
[TBL] [Abstract][Full Text] [Related]
20. SUMO modification regulates the transcriptional activity of MAML1.
Lindberg MJ; Popko-Scibor AE; Hansson ML; Wallberg AE
FASEB J; 2010 Jul; 24(7):2396-404. PubMed ID: 20203086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
